Duck Circovirus

Overview and Taxonomy of Duck Circovirus

Duck circovirus (DuCV) represents a significant and increasingly recognized viral pathogen within the global domestic waterfowl industry, particularly in Asia where duck production is intensive. The virus is a member of the family Circoviridae, genus Circovirus, and is etiologically linked to a multifaceted disease syndrome characterized primarily by immunosuppression, growth retardation, feathering disorders, and enhanced susceptibility to secondary viral and bacterial infections [1, 5, 15]. The clinical and subclinical impacts of DuCV infection are now understood to impose substantial economic burdens on duck farming operations, a concern that has been echoed in reports and surveillance efforts by regional veterinary authorities and aligns with global priorities for emerging infectious disease monitoring as defined by the World Organisation for Animal Health (WOAH). The virus was first identified in the early 2000s, and since its initial characterization, a remarkable genetic diversity has been uncovered, leading to the establishment of a complex genotypic framework that continues to evolve with the discovery of novel strains and recombinant forms [5, 9, 11].

From a taxonomic perspective, the Circoviridae family encompasses small, non-enveloped viruses with a circular, single-stranded DNA (ssDNA) genome. DuCV is a quintessential member, possessing a genome ranging from approximately 1,755 to 1,996 nucleotides (nt) in length, a size variation that has become a hallmark of its genetic plasticity [1, 2, 9]. The archetypal DuCV genome structure, characteristic of the genus Circovirus, is ambisense and contains at least two major open reading frames (ORFs). ORF1, located on the viral sense strand, encodes the replication-associated protein (Rep), a highly conserved enzyme critical for rolling-circle replication of the viral genome. ORF2, on the complementary sense strand, encodes the capsid protein (Cap), the sole structural protein that constitutes the viral icosahedral shell and serves as the primary antigenic determinant [7, 16]. A third ORF, ORF3, has been identified and is known to encode a protein that induces apoptosis through the mitochondrial pathway, contributing directly to the lymphocytic depletion and immunosuppression observed in infected birds [8]. The intergenic region between the rep and cap genes is of considerable functional importance, harboring a quadruple tandem repeat sequence (QTR) unique to DuCV, which functions as a downstream sequence element (DSE) to regulate viral gene expression and mRNA stability [16]. This distinctive genomic feature is not found in other circoviruses and has been proposed as a novel molecular marker for DuCV genotyping [16].

Phylogenetically, DuCV isolates have been historically classified into two major genotypes, DuCV-1 and DuCV-2, which share approximately 83% nucleotide identity across their complete genomes [9, 12]. This binary classification, however, belies a far more intricate sub-structure. Extensive molecular epidemiological studies, particularly those conducted in China, the epicenter of DuCV research and diversity, have delineated multiple subtypes and lineages within these genotypes. Li et al. (2025) conducted a comprehensive genetic and evolutionary analysis of 51 near-full-length DuCV genome sequences obtained from 17 provinces across China in 2022, establishing that DuCV-1b and DuCV-2c are the most prevalent and actively co-circulating strains nationally [3]. Subsequent work by Dong et al. (2025) on DuCV strains circulating in Northern Vietnam identified genotype I strains, further subdivided into subgenotypes Ia, Ib, and Ic, demonstrating that the genetic architecture of DuCV transcends national borders and is a regional phenomenon [4]. The discovery and characterization of a novel subtype, DuCV-1d, in Anhui and Fujian provinces of China added a critical layer to this taxonomic structure [11, 14]. These DuCV-1d strains were shown to arise from specific recombination patterns, highlighting the role of genetic exchange in driving viral diversity [14].

The most profound recent taxonomic development has been the identification of a third, distinct genotype, provisionally designated duck circovirus 3 (DuCV3). Liao et al. (2022) isolated this novel virus from laying ducks exhibiting egg production decline in Hunan province, China. With a genome of only 1,755 nt, substantially smaller than DuCV-1 and DuCV-2, DuCV3 shares only 62.3–63.7% genome-wide identity with known DuCVs and 66.3–67.8% identity with goose circoviruses (GoCV) [9]. Phylogenetic analyses based on both Rep and Cap amino acid sequences placed DuCV3 in a separate, distinct clade, corroborating its status as a new species within the genus [9]. This discovery fundamentally altered the understanding of circovirus diversity in ducks and raised critical questions regarding the evolutionary origins and host range of these viruses. DuCV is not confined solely to domestic ducks (Anas platyrhynchos domesticus and Cairina moschata). The host range has expanded to include geese, with Xu et al. (2024) first reporting the detection of DuCV-1 and DuCV-2 genotypes in geese in China, providing direct evidence for cross-species transmission between ducks and geese [6]. Furthermore, DuCV sequences have been identified in wild marine ducks, such as the velvet scoter (Melanitta fusca) in Poland, and in Brazilian Pekin ducks via viral metagenomics, suggesting a broad and possibly underappreciated ecological niche, with wild waterfowl potentially serving as reservoirs [13, 18]. Codon usage bias analyses across five different poultry hosts have further illuminated the adaptive pressures shaping DuCV evolution, revealing that the Cap protein preferentially uses codons ending in A and that the codon preferences of DuCV-3 Rep are more similar to GoCV than to DuCV-1 or DuCV-2, hinting at a complex evolutionary history involving host adaptation and potential inter-genotype recombination [10].

Recombination is a major driving force in the evolution and genotypic diversification of DuCV. Numerous studies have documented inter-genotypic and intra-genotypic recombination events across various genomic regions, particularly within the cap gene and the intergenic region [3, 11, 12, 14, 17]. Ji et al. (2020) demonstrated that 15 out of 20 new DuCV strains from central and eastern China were likely derived through such recombination events, and a novel recombinant event between DuCV-1 and DuCV-2 was identified in a strain from Yunnan [11, 17]. These recombination events are not geographically isolated; they have been detected between strains from different Chinese provinces and between strains from different countries, such as Vietnam and China, underscoring the fluid and interconnected nature of the global DuCV population [3, 4]. The constant emergence of new recombinants, coupled with the identification of DuCV3, underscores that the current taxonomic framework for DuCV is dynamic and likely incomplete. As such, ongoing molecular surveillance and phylogenomic characterization are not merely academic exercises but are essential for the development of broadly protective vaccines and for understanding the pathobiological implications of this exceedingly diverse and ever-evolving immunosuppressive pathogen.

Molecular Virology and Genomic Characterization of Duck Circovirus

Genome Architecture and Conserved Structural Features

Duck circovirus (DuCV) possesses one of the smallest known viral genomes among circoviruses infecting avian species, with a circular, single-stranded DNA genome ranging from 1,755 to 1,996 nucleotides (nt) depending on the genotype and strain [2, 9, 11]. The genome is ambisense, encoding at least three major open reading frames (ORFs): ORF1 (Rep), ORF2 (Cap), and ORF3 (apoptosis-related protein), along with a characteristic stem–loop structure that serves as the origin of rolling-circle replication (RCR) [5, 7]. The intergenic region between the rep and cap genes harbors a unique quadruple tandem repeat (QTR) sequence that is evolutionarily conserved within each genotype and functions as a downstream sequence element (DSE) to enhance mRNA stability and regulate viral gene expression [16]. This QTR is absent in other circoviruses, making it a distinctive molecular marker for DuCV genotyping [16].

The complete genome of the prototype DuCV-1 strain (e.g., German strain AY228555) is 1,993–1,996 nt, while DuCV-2 genomes are slightly shorter (1,987–1,992 nt) [2, 7, 17]. A novel circovirus species, tentatively designated DuCV-3, was identified in laying ducks from Hunan, China, with a markedly smaller genome of only 1,755 nt, sharing only 62.3–63.7% genome-wide identity with DuCV-1 and DuCV-2 and less than 50% identity with other circoviruses [9]. This discovery underscores the remarkable genetic plasticity and diversity within duck circoviruses.

Replication Protein (Rep): Enzymatic Activities and Mechanistic Insights

The Rep protein, encoded by ORF1, is a highly conserved multifunctional enzyme essential for viral replication. It exhibits both ATPase and helicase activities, functioning as a replicative helicase that unwinds double-stranded DNA in an ATP-driven, metal ion-dependent manner with a 3′→5′ directionality [19]. Biochemical characterization of recombinant DuCV Rep revealed that the enzyme can hydrolyze any nucleoside triphosphate (NTP) to generate energy for unwinding, but ATP analogs and hydrolysates cannot substitute for ATP [19]. The unwinding activity requires a 3′-terminal single-strand extension (3′-overhang) of at least 1 nucleotide; efficiency increases with longer overhangs but decreases with longer duplex regions [19]. These properties are consistent with a rolling-circle replication mechanism, where Rep nicks the origin, remains covalently attached to the 5′ end, and unwinds the template to allow complementary strand synthesis.

The Rep protein also serves as a target for antiviral strategies and diagnostic assays. A CRISPR/Cas12a-based lateral flow strip detection method targeting the rep gene achieved a limit of detection of 2.6 copies, demonstrating the utility of Rep as a molecular target [25]. Additionally, an indirect ELISA using recombinant Rep protein can differentiate natural infection from vaccination, as Rep antibodies are only produced during active replication [21].

Capsid Protein (Cap): Structure, Antigenicity, and Host Interaction

The capsid protein (Cap), encoded by ORF2, is the sole structural protein and the primary immunogen. The Cap gene is 762 nt in length, encoding a protein of approximately 27–30 kDa [20, 24]. The N-terminal region contains a nuclear localization signal (NLS) that directs Cap to the nucleus, where viral assembly is thought to occur [34]. Deletion of the NLS alters subcellular localization to the cytoplasm, and fusion with a secretory signal peptide enhances extracellular secretion and immunogenicity [34].

Cap self-assembles into virus-like particles (VLPs) of approximately 15–20 nm when expressed in Escherichia coli or Pichia pastoris [30, 35]. These VLPs exhibit morphology indistinguishable from native virions and are highly immunogenic, eliciting stronger antibody responses than monomeric Cap [30]. A monoclonal antibody (mAb) generated against recombinant Cap lacking the first 36 N-terminal amino acids recognizes a linear epitope (144IDKDGQIV151) exposed on the virion surface, enabling detection of native viral antigen in infected tissues and cells [28].

Crucially, Cap mediates viral attachment to host cells. The protein binds to the extracellular loops EL1 and EL2 of duck claudin-2 (CLDN2), a tight junction protein. This interaction triggers activation of the MAPK-ERK signaling pathway, leading to upregulation of the transcription factor SP5, which in turn enhances CLDN2 expression and promotes further viral adherence and infection [26]. This mechanism is particularly relevant for vertical transmission, as DuCV infects the oviduct and ovary of female breeding ducks, and Cap–CLDN2 binding facilitates infection of reproductive tissues [26].

ORF3 Protein: Apoptosis and Immunosuppression

The ORF3 protein, unique to DuCV and some other circoviruses, plays a pivotal role in pathogenesis by inducing apoptosis. In DuCV genotype 2, ORF3 activates the mitochondrial (intrinsic) apoptotic pathway in duck embryo fibroblasts (DEFs), as evidenced by nuclear shrinkage, chromosomal DNA fragmentation, upregulation of caspase-3 and caspase-9, and decreased mitochondrial membrane potential [8]. The C-terminal 20 amino acids are essential for this pro-apoptotic function; deletion of this region (ORF3ΔC20) significantly reduces apoptosis rates and downregulates key mediators such as cytochrome c, PARP, and Apaf-1 [8]. ORF3-mediated apoptosis of lymphocytes in the bursa of Fabricius, thymus, and spleen is a major contributor to the immunosuppression characteristic of DuCV infection [15, 33].

Genetic Diversity, Genotypes, and Recombination

Phylogenetic analyses based on complete genome sequences have delineated three major genotypes: DuCV-1, DuCV-2, and the recently proposed DuCV-3 [9, 11]. DuCV-1 is further subdivided into subgenotypes 1a, 1b, 1c, and 1d [4, 11, 14]. DuCV-2 includes subgenotypes 2a, 2b, and 2c [3]. The nucleotide identity between DuCV-1 and DuCV-2 is approximately 83%, while DuCV-3 shares only 62–68% identity with the other two genotypes [9].

Recombination is a major driver of DuCV evolution. Inter-genotypic and intra-genotypic recombination events have been frequently detected, particularly within the cap gene and intergenic regions [3, 11, 17]. For example, a novel recombinant strain (YN26/2013) from Yunnan, China, arose from recombination between DuCV-1 and DuCV-2 within the 987–1111 nt region [17]. In Vietnam, three DuCV strains exhibited recombination breakpoints in the Cap gene, and one positive selection site was identified in Rep [4]. In China, major parental sequences for recombinants originate from Anhui, Sichuan, Shandong, and Guangxi provinces, and recombination can occur between strains of different genotypes or even between strains from different countries [3]. The emergence of the DuCV-1d subtype in Anhui and Fujian provinces is associated with a specific recombination pattern [11, 14].

Codon Usage Bias and Host Adaptation

Codon usage analysis of DuCV and goose circovirus (GoCV) across five poultry hosts revealed that the Cap gene preferentially uses codons ending in A, driven primarily by selective pressure rather than mutational bias [10]. Principal coordinate analysis showed that synonymous codon usage patterns (CUPs) among GoCV strains are relatively homogeneous, whereas DuCV-1, DuCV-2, and DuCV-3 exhibit greater divergence. Notably, the codon preference of DuCV-3 Rep is more similar to GoCV than to DuCV-1 or DuCV-2, suggesting a possible evolutionary link or cross-species transmission event [10]. GoCV strains identified in ducks have a higher Codon Adaptation Index (CAI) than goose-origin GoCVs, indicating better adaptation to duck hosts [10]. These findings have implications for vaccine design, as codon optimization of the Cap gene for expression in yeast or bacterial systems can dramatically increase protein yield [35].

Molecular Epidemiology and Global Distribution

DuCV has been detected worldwide, including in China, South Korea, Thailand, Vietnam, Brazil, Poland, and other regions [3, 13, 18, 23, 24, 36]. In China, a large-scale epidemiological survey in 2022 involving 2,944 samples from 17 provinces found an overall positivity rate of 20.8%, with Fujian (54.8%) and Guangxi (30.4%) having the highest rates [3]. DuCV-1b and DuCV-2c were the predominant circulating genotypes [3]. In South Korea, all 24 strains analyzed between 2011 and 2012 belonged to DuCV-1, with 10 amino acid substitutions in Cap compared to other genotype 1 strains [38]. In Thailand, DuCV genotype I was subdivided into subgenotype Ib and an unclassified subgenotype, with variations in 10 Cap residues [24]. The detection of DuCV in velvet scoter (Melanitta fusca) in Poland, with 84–86% nucleotide identity to known DuCV-1 strains, suggests that wild marine ducks may serve as reservoirs [18]. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) recognize circovirus infections as economically significant for poultry industries, and the increasing prevalence of DuCV underscores the need for international surveillance and control measures.

Molecular Detection and Diagnostic Tools

A wide array of molecular techniques has been developed for DuCV detection, reflecting the virus's global importance. Real-time quantitative PCR (qPCR) assays targeting the Rep or Cap genes achieve detection limits as low as 1–20 copies/μL and can differentiate DuCV-1 and DuCV-2 [22, 31, 39]. Multiplex qPCR and digital PCR platforms enable simultaneous detection of DuCV with other duck pathogens such as novel goose parvovirus, duck Tembusu virus, and duck adenovirus 3 [22, 27]. Isothermal amplification methods, including loop-mediated isothermal amplification (LAMP), recombinase-aided amplification (RAA), and CRISPR/Cas12a-based lateral flow strips, provide rapid, field-deployable diagnostics with sensitivities comparable to qPCR [25, 29, 32, 37]. Serological assays based on recombinant Cap or VLPs offer high sensitivity (97.5–100%) and specificity (98.1–100%) for large-scale surveillance [20, 21, 30]. The availability of these tools is critical for monitoring DuCV evolution, assessing vaccine efficacy, and implementing biosecurity measures.

Epidemiology and Transmission Dynamics of Duck Circovirus

Global Distribution and Prevalence

Duck circovirus (DuCV) has emerged as a ubiquitous pathogen in the global duck industry, with its presence documented across virtually all major duck-producing regions. The epidemiological landscape of DuCV is characterized by high infection rates, genetic diversity, and a complex interplay of transmission mechanisms that have facilitated its rapid dissemination. Comprehensive epidemiological investigations have revealed that DuCV infection is not merely a sporadic occurrence but rather an endemic reality in commercial duck flocks, with prevalence rates varying significantly by geographic region, age cohort, and diagnostic methodology.

In China, which represents the world's largest duck production hub, the epidemiological footprint of DuCV is particularly pronounced. A large-scale surveillance study conducted across 17 provinces from January to October 2022, encompassing 2,944 waterfowl samples, identified 612 DuCV-positive specimens, yielding an overall positivity rate of 20.79% [3]. However, this aggregate figure masks substantial regional heterogeneity. Fujian Province exhibited the highest prevalence at an alarming 54.8%, followed by the Guangxi Zhuang Autonomous Region at 30.4% [3]. These findings align with earlier investigations in southern and southwestern China (2018–2019), where 313 of 848 bursal samples (36.91%) tested positive across Guangdong, Guangxi, and Yunnan provinces, with Yunnan showing the highest provincial rate at 43.09% [12]. The temporal persistence and geographic expansion of DuCV underscore its transition from an emerging pathogen to an established endemic threat.

Outside of China, the epidemiological data paint a similarly concerning picture. In South Korea, longitudinal surveillance from 2013 to 2022 has documented the sustained circulation of DuCV, with early studies reporting a 21.8% prevalence in subclinical Pekin ducks across five provinces between 2011 and 2012 [23, 46]. A subsequent focused investigation in Jeonbuk province detected DuCV in 40 of 104 samples (38.5%) [36]. In Southeast Asia, Thailand's duck farms have demonstrated active DuCV circulation, with phylogenetic analyses confirming the presence of genotype I strains among flocks exhibiting feather abnormalities and growth retardation [24]. Northern Vietnam reported a 35.56% positivity rate among 45 pooled tissue samples collected from nine duck flocks between 2023 and 2025, with the nine representative sequenced strains clustering within genotype I and its subgenotypes [4]. Even in South America, viral metagenomic analysis of Pekin ducks in Southern Brazil has identified DuCV sequences, confirming its intercontinental dissemination [13]. Critically, DuCV is not confined to domestic waterfowl; its detection in wild velvet scoter ducks (Melanitta fusca) along the Baltic coast of Poland, with nucleotide similarity of 84–86% to known DuCV strains, suggests that wild avian reservoirs may play a significant role in the virus's ecology and long-distance dispersal [18].

Host Range and Age-Related Susceptibility

The host tropism of DuCV extends beyond the traditional Anas platyrhynchos domesticus (Pekin duck) and Cairina moschata (Muscovy duck) to encompass a remarkable breadth of waterfowl species. Epidemiological surveys have confirmed infection in Cherry Valley meat ducks, Mulard ducks, Mallard ducks, and even geese, with the first identification of DuCV in goose flocks in China representing a significant host range expansion [6, 12]. This trans-species transmission is particularly concerning from an evolutionary perspective, as codon usage bias analyses have demonstrated that the capsid (Cap) protein of both DuCV and goose circovirus preferentially utilizes codons ending in adenine, with this preference being shaped primarily by selective pressure rather than mutational bias [10]. The codon adaptation index analyses further reveal that goose circoviruses identified in duck hosts exhibit the highest adaptation values, indicating ongoing cross-species adaptation and the potential for further host range expansion [10].

Age-dependent susceptibility is a defining epidemiological feature of DuCV infection. Multiple independent studies converge on the finding that young ducks, particularly those between 3 and 6 weeks of age, represent the most vulnerable demographic. In the comprehensive 2022 Chinese survey, samples from 21- to 40-day-old ducklings accounted for 66.5% of all positive detections [3]. This pattern is corroborated by experimental infections: when one-day-old Cherry Valley ducklings were inoculated with DuCV-1, viral DNA was detectable in serum, cloacal swabs, and throat swabs as early as 1 day post-infection (DPI) and persisted throughout the 35-day experimental period [1]. Similarly, in Pekin ducks, viremia was first detected at 1 week post-infection (WPI), with viral shedding continuing up to 10 WPI [15]. The increasing prevalence with age, as documented in South Korean studies where 3-week-old ducks showed significantly higher positivity rates than 1-week-old ducks, suggests that cumulative environmental exposure and the breakdown of maternal antibody protection contribute to the age-related infection pattern [36, 46]. This age distribution has profound implications for biosecurity timing and intervention strategies.

Genotypic Diversity and Evolutionary Dynamics

The genetic architecture of DuCV is characterized by remarkable diversity, which has been systematically classified into distinct genotypes and subgenotypes. Historically, two major genotypes, DuCV-1 and DuCV-2, were defined based on genome-wide nucleotide identities of approximately 83% [9]. However, recent molecular epidemiological studies have substantially refined this classification. Phylogenetic analyses of 51 near-full-length DuCV genome sequences from the 2022 Chinese surveillance revealed that DuCV-1b and DuCV-2c were the most prevalent circulating strains, with co-circulation of both genotypes observed in several provinces [3]. The complexity is further underscored by the identification of a novel subtype, DuCV-1d, first recognized in six strains from Fujian Province and subsequently confirmed in Anhui Province, bringing the total recognized subgenotypes to at least four (DuCV-1a, -1b, -1c, and -1d) within genotype I alone [11, 14].

The emergence of novel genotypes continues to reshape our understanding of DuCV diversity. In 2022, a distinct circovirus was identified in laying ducks from Hunan Province, China, exhibiting a genome size of only 1,755 nucleotides, substantially smaller than the typical 1,987–1,996 nt of classical DuCV strains [9]. This virus, tentatively designated duck circovirus 3 (DuCV3), shares only 62.3–63.7% genome-wide identity with known DuCVs and 66.3–67.8% with goose circoviruses, clustering in a separate phylogenetic clade that justifies its classification as a novel circovirus species [9]. The clinical significance of DuCV3, particularly its association with egg production decline or abrogation, warrants urgent investigation. The existence of such genetic diversity complicates vaccine development efforts, as the protective efficacy of any candidate vaccine must be carefully evaluated against multiple genotypes [3].

Recombination is a major driving force in DuCV evolution and epidemiological expansion. Genetic recombination analysis of 51 Chinese strains identified major parental sequences originating from Anhui, Sichuan, Shandong, and Guangxi provinces, with recombination events occurring between different genotypes and even between strains isolated from different countries [3]. In Vietnam, recombination breakpoints were identified within the Cap gene sequences of three strains (Vietnam/VNUA-102/2023, Vietnam/VNUA-225/2023, and Vietnam/VNUA-318/2024), with one positive selection signal detected on the Rep protein sequence [4]. A novel recombinant DuCV strain, YN26/2013, isolated from a Muscovy duck in Yunnan Province, demonstrated a recombination event between DuCV-1 and DuCV-2 within the 987–1111 nucleotide region, highlighting the ongoing genetic exchange between genotypes [17]. Among 20 DuCV strains sequenced from central and eastern China, 15 were derived from inter-genotypic or intra-genotypic recombination events, underscoring the pervasive nature of this evolutionary mechanism [11]. These recombination events, coupled with the hypervariable regions identified in ORF2 (Cap), ORF3, and intergenic regions, enable rapid antigenic variation that may facilitate immune evasion and complicate serological surveillance [11].

Transmission Dynamics: Horizontal and Vertical Pathways

The transmission biology of DuCV is multifaceted, encompassing both horizontal and vertical routes that collectively contribute to its high prevalence and persistence in duck populations. Understanding these transmission pathways is critical for designing effective control measures.

Horizontal transmission is the primary mechanism by which DuCV spreads within and between flocks. Experimental infection studies have conclusively demonstrated that DuCV-1 can be transmitted horizontally, with viral DNA detected in serum, cloacal swabs, and throat swabs as early as 1 DPI and persisting throughout the observation period [1]. The detection of virus in both cloacal and throat swabs indicates that the fecal-oral and oropharyngeal routes are likely the predominant modes of horizontal spread. In Pekin ducks experimentally infected with DuCV-1, viral shedding was persistent and detectable for up to 10 weeks post-infection, confirming that infected birds serve as continuous sources of environmental contamination [15]. The virus exhibits broad tissue tropism, with initial detection in the liver and highest viral titers observed in the thymus, followed by the spleen, bursa of Fabricius, cecal tonsil, lung, liver, and kidney [1, 15]. This systemic distribution facilitates viral shedding through multiple routes, including feces, respiratory secretions, and potentially feather follicles, thereby amplifying environmental contamination.

The dynamics of viral replication in target organs follow a characteristic temporal pattern. In specific-pathogen-free (SPF) ducks experimentally infected with the SDDC strain, multi-organ viral dynamics revealed detectable viral presence across target organs as early as 3 DPI, followed by a progressive decline until day 7, a pronounced replication peak at day 14, and subsequent gradual viral clearance [2]. This biphasic replication pattern, with an early eclipse phase followed by a robust peak, may reflect initial immune containment followed by viral escape or replication in immunoprivileged sites. The spleen, identified as the primary target organ with the highest viral load and significant histopathological alterations, likely serves as a central lymphoid reservoir for viral amplification and dissemination [2].

Vertical transmission represents a particularly insidious route of DuCV spread, enabling the virus to circumvent conventional biosecurity measures and infect successive generations. Clinical evidence has long suggested the potential for vertical transmission through duck embryos to progeny, but definitive experimental confirmation was lacking until recent studies. Shen et al. (2024) elegantly demonstrated that oral DuCV infection in female breeding ducks leads to infection of the oviduct, ovary, and ovarian follicles [26]. This reproductive tract infection subsequently transmits to fertilized eggs, resulting in the emergence of virus-carrying ducklings upon hatching. Critically, the reproductive organs of male breeding ducks remained unaffected by the virus, confirming that vertical transmission primarily occurs through infected female breeders [26].

The molecular basis of vertical transmission involves a sophisticated host-virus interaction mediated by the tight junction protein claudin-2 (CLDN2). Transcriptome sequencing of DuCV-infected oviducts revealed significantly increased CLDN2 expression, and the DuCV capsid protein (Cap) was confirmed to interact with the extracellular loop domains EL1 and EL2 of CLDN2 through co-immunoprecipitation, GST pull-down, immunofluorescence, and adhesion-blocking assays [26]. DuCV infection triggers activation of the MAPK-ERK signaling pathway in duck embryo fibroblasts and ducks, leading to upregulation of the transcription factor SP5, which in turn drives CLDN2 transcription [26]. This feed-forward loop results in increased CLDN2 expression on the cell surface, facilitating enhanced viral adherence to target organs, including the oviduct. The intracellular Cap protein also interacts directly with SP5, further amplifying CLDN2 transcription [26]. This elegant mechanism not only explains vertical transmission but also identifies CLDN2 as a promising therapeutic target for blocking DuCV infection.

The epidemiological significance of vertical transmission is substantiated by field observations. Coinfection of novel goose parvovirus (NGPV) and DuCV was documented in duck embryos and in ducks with beak atrophy and dwarfism syndrome (BADS), with evidence suggesting vertical transmission of both viruses [45]. The ability of DuCV to establish persistent infection in breeding flocks, combined with vertical transmission, creates a self-perpetuating cycle of infection that is notoriously difficult to break. This has profound implications for hatchery biosecurity and breeder flock management.

Mixed Infections and Synergistic Pathogenicity

Perhaps the most consequential epidemiological feature of DuCV is its role as an immunosuppressive pathogen that predisposes ducks to secondary and concurrent infections. The phenomenon of mixed infection is not merely incidental but appears to be a defining characteristic of DuCV epidemiology, with profound implications for disease expression and clinical outcome.

Field surveys consistently document high rates of coinfection. In the 2022 Chinese epidemiological study, the most common pathogens identified in mixed infections with DuCV were parvovirus and Riemerella anatipestifer [3]. In Thailand, DuCV-infected ducks exhibited coinfections with Riemerella anatipestifer, Escherichia coli, Pasteurella multocida, duck viral enteritis virus, and duck Tembusu virus [24]. A comprehensive surveillance of 396 clinical specimens collected from duck farms in China between June 2022 and July 2023 using a quadruplex real-time quantitative PCR assay revealed detection rates of 33.58% for DuCV, 8.33% for Muscovy duck parvovirus, 17.93% for goose parvovirus, and 29.04% for duck adenovirus 3, with substantial overlap among these pathogens [22]. Similarly, in central and eastern China, 100% of DuCV-positive farms from which 219 dead ducks were sampled exhibited coinfection with duck-origin goose parvovirus [11].

The biological basis for these high coinfection rates lies in DuCV's profound immunosuppressive effects. Experimental coinfections have systematically demonstrated that DuCV synergistically amplifies the pathogenicity of other pathogens. In Cherry Valley ducks co-infected with DuCV and fowl adenovirus serotype 4 (FAdV-4), co-infected birds exhibited more pronounced clinical signs of pericardial effusion, hepatitis, and immunosuppression, with more severe tissue damage in target organs and significantly higher levels of viral load in various organs compared to single-virus infections [40]. The mechanism appears to involve DuCV-induced lymphocyte depletion and immune organ atrophy, which creates an immunological vacuum that allows secondary pathogens to replicate unchecked.

The interaction between DuCV and novel goose parvovirus (NGPV) is particularly well-characterized and clinically significant. Co-infection of DuCV and NGPV in Cherry Valley ducks resulted in the manifestation of short beak and dwarfism syndrome (SBDS), a condition that is difficult to reproduce with NGPV infection alone [42, 45]. Co-infected ducks exhibited continuous detection of both viruses in serum and swabs from 1 DPI onward, with viral loads significantly higher than those in single-infection groups, along with severe immunosuppression, tissue damage, and metabolic disturbances [42]. Histopathological examination revealed synergistic amplification of pathogenicity, with extended viral distribution in the liver, kidney, duodenum, spleen, and bursa of Fabricius [44]. The temporal dynamics of this synergy are notable: in the early stage of infection (first week), viral loads of both pathogens in co-infected ducks were significantly lower than those in mono-infected ducks, but with disease progression, viral loads in co-infected ducks became significantly higher, indicating that the immunosuppressive effects of DuCV require time to manifest fully [44].

The clinical syndrome of feather shedding syndrome (FSS) in Cherry Valley ducks further illustrates the pathogenic synergy between DuCV and NGPV. Analysis of 540 feather sac samples from ducks with FSS revealed NGPV and DuCV infection rates of 82.78% and 78.89%, respectively, with a coinfection rate of 70.00% [43]. Ducks aged 4–5 weeks presented the most severe FSS in flocks with the highest co-detection rates [43]. This association suggests that DuCV-mediated immunosuppression may facilitate NGPV replication in feather follicles, leading to the characteristic feather abnormalities.

The interaction between DuCV and avian pathogenic Escherichia coli (APEC) provides additional evidence for DuCV's role in predisposing ducks to bacterial infections. Experimental co-infection demonstrated that DuCV infection significantly enhanced APEC pathogenicity and colonization ability in vivo, with more severe APEC infection observed at 24 DPI than at 14 DPI, correlating with the progressive immunosuppression induced by DuCV [41]. Immune function monitoring revealed decreased lymphocyte transformation rates, reduced interleukin-12, soluble CD4, soluble CD8, and interferon-γ levels, and increased interleukin-10 content, confirming the immunosuppressive state that facilitates bacterial superinfection [41].

The implications of these mixed infection dynamics for diagnosis, treatment, and control are profound. The presence of DuCV in a flock should alert clinicians to the likelihood of concurrent infections, and diagnostic protocols must incorporate multiplex detection methods to identify all contributing pathogens. The World Organisation for Animal Health (WOAH) recognizes the importance of immunosuppressive diseases in poultry production, and the economic burden of DuCV-associated co-infections necessitates integrated control strategies that address both the primary viral infection and the secondary pathogens it enables.

Pathogenesis and Clinical Manifestations of Duck Circovirus Infection

The pathogenesis of Duck Circovirus (DuCV) infection is a multifaceted process characterized by a primary, often subclinical, phase that rapidly evolves into a state of profound immunosuppression, systemic dissemination, and heightened susceptibility to secondary pathogens. Understanding the intricate molecular mechanisms by which DuCV establishes infection, evades host defenses, and induces pathology is critical for developing effective control strategies. The clinical manifestations, while variable, are consistently linked to the virus’s tropism for lymphoid tissues and its capacity to disrupt normal immune function.

Molecular Mechanisms of Viral Entry and Cellular Tropism

The initial steps of DuCV infection involve viral attachment and entry into susceptible host cells. Recent groundbreaking research has elucidated a key molecular interaction that governs this process. Shen et al. (2024) demonstrated that the DuCV capsid (Cap) protein directly interacts with the host cell membrane protein claudin-2 (CLDN2), a tight junction component [26]. Specifically, the Cap protein binds to the extracellular loop domains EL1 and EL2 of CLDN2, facilitating viral adherence to target cells [26]. This interaction is not merely a passive docking event; it triggers a signaling cascade within the host cell. DuCV infection activates the mitogen-activated protein kinase-extracellular signal-regulated kinase (MAPK-ERK) signaling pathway in duck embryo fibroblasts (DEFs) and in vivo [26]. This activation leads to the upregulation of the transcription factor SP5, which in turn enhances the transcription of the CLDN2 gene [26]. The resulting increase in CLDN2 protein on the cell surface creates a positive feedback loop, promoting further viral adhesion and infection [26]. This mechanism provides a sophisticated explanation for DuCV’s broad tissue tropism, as CLDN2 is expressed in various epithelial and endothelial tissues, including the oviduct, which is central to the virus’s ability to establish vertical transmission [26].

Once inside the cell, viral replication is orchestrated by the Rep protein, a highly conserved enzyme with dual enzymatic activities. Tao et al. (2025) characterized the biochemical properties of DuCV Rep, revealing that it possesses both ATPase and helicase activities [19]. Rep unwinds double-stranded DNA (dsDNA) in a 3′ to 5′ direction, a process that is dependent on the hydrolysis of nucleoside triphosphates (NTPs) and the presence of divalent metal ions [19]. The efficiency of this unwinding is influenced by the length of the 3′-overhang on the DNA substrate, with longer overhangs enhancing activity [19]. This helicase function is essential for rolling-circle replication, the mechanism by which circoviruses replicate their circular genomes. Furthermore, the virus’s genome contains a unique quadruple tandem repeat sequence (QTR) in the intergenic region, which functions as a downstream sequence element (DSE) to enhance mRNA stability and regulate viral gene expression, a feature not found in other circoviruses [16].

Pathogenesis of Immunosuppression and Lymphoid Depletion

The hallmark of DuCV pathogenesis is its profound and sustained immunosuppression, which is primarily driven by the virus’s tropism for and destruction of lymphoid tissues. Experimental infections in Cherry Valley ducks and specific-pathogen-free (SPF) ducks have consistently demonstrated that DuCV targets the thymus, spleen, and bursa of Fabricius (BF) [1, 2, 15, 48]. The thymus, a primary lymphoid organ responsible for T-cell maturation, often harbors the highest viral titers, as observed in DuCV-1-infected Cherry Valley ducks [1]. The spleen and BF, key secondary and primary lymphoid organs, respectively, also show significant viral loads and pathological damage [2, 15, 48]. Histopathological examination reveals severe lymphocyte depletion, necrosis, and atrophy within these organs [15, 48]. In the BF, this manifests as hemorrhage, lymphocytic depletion, and degeneration of bursal follicles [15]. The resulting reduction in immune cell populations directly compromises both humoral and cell-mediated immunity.

The molecular basis for this lymphoid depletion involves the induction of apoptosis. The DuCV genome encodes an ORF3 protein, which has been identified as a key pro-apoptotic factor. Huang et al. (2023) demonstrated that the DuCV-2 ORF3 protein induces apoptosis in DEFs through the mitochondrial (intrinsic) pathway [8]. This was evidenced by nuclear shrinkage, chromosomal DNA fragmentation, and the upregulation of caspase-3 and caspase-9, key executioners of the mitochondrial apoptotic cascade [8]. The C-terminal 20 amino acid residues of ORF3 were found to be critical for this function, as their deletion (ORF3ΔC20) reduced apoptosis rates and downregulated key mitochondrial pathway molecules such as cytochrome c (Cyt c) and apoptosis protease activating factor 1 (Apaf-1) [8]. This virus-induced apoptosis of lymphocytes within the immune organs is a direct mechanism of immunosuppression, creating a permissive environment for secondary infections.

The functional consequences of this lymphoid destruction are severe. Infected ducks exhibit significantly decreased immune organ indexes (organ weight relative to body weight) [1]. At the cellular level, there is a marked reduction in the lymphocyte transformation rate (LTR), indicating impaired T-cell proliferative capacity [41]. Cytokine profiling reveals a shift towards an immunosuppressive state, with decreased levels of pro-inflammatory and antiviral cytokines such as IL-12, IFN-γ, and soluble CD4 (sCD4) and CD8 (sCD8), alongside an increase in the immunosuppressive cytokine IL-10 [41]. This dysregulation of the cytokine network further cripples the host’s ability to mount an effective immune response against both the primary virus and opportunistic pathogens.

Systemic Dissemination and Multi-Organ Pathology

DuCV is not confined to lymphoid tissues; it exhibits a broad tissue tropism, leading to a systemic infection. Following experimental inoculation, viral DNA can be detected in a wide array of organs, including the liver, kidney, lung, heart, duodenum, cecal tonsil, and even the brain [1, 2, 15, 48]. The kinetics of viral dissemination follow a characteristic pattern. In SPF ducks infected with DuCV-1, viral presence is detectable in target organs as early as 3 days post-infection (dpi), followed by a progressive decline until day 7, after which a pronounced replication peak occurs around 14 dpi, before gradual clearance [2]. In Cherry Valley ducks, viremia and viral shedding in cloacal and throat swabs can be detected as early as 1 dpi and persist throughout the experimental period, highlighting the virus’s ability to establish persistent infections [1].

The liver is a major target organ, and DuCV infection induces significant hepatic pathology. A particularly striking finding is the induction of primary sclerosing cholangitis (PSC), a chronic cholestatic liver disease characterized by cholangiocytic injury and progressive fibrous obliteration of the biliary tree, accompanied by lymphocytic infiltration [33]. DuCV shows a higher tropism for bile duct epithelial cells than for hepatocytes, explaining this specific pathology [33]. This is reflected in serum biochemical alterations, including significant increases in alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyl transferase (GGT), and total bilirubin (TBIL), alongside decreased levels of calcium and phosphorus [1, 33]. These changes indicate both hepatocellular damage and cholestasis.

The spleen, another primary target, shows the highest viral load in some studies [2, 15]. Histopathological lesions in the spleen include lymphoid depletion and necrosis, contributing to the overall immunosuppressive state [48]. The virus also infects the respiratory and digestive tracts, contributing to clinical signs such as respiratory tissue swelling and enteritis [5]. The ability of DuCV to infect the reproductive tract of female breeding ducks, including the oviduct, ovary, and follicles, is a critical aspect of its pathogenesis, enabling vertical transmission to embryos and hatched ducklings [26].

Clinical Manifestations and the Role of Co-infections

The clinical manifestations of DuCV infection are highly variable and often subclinical in the absence of secondary pathogens. However, when clinical signs do appear, they are characteristic of a chronic, wasting, immunosuppressive disease. The most commonly reported signs include feathering disorders (feather loss, abnormal feather development), growth retardation, and low body weight [1, 5, 15, 24]. Affected ducks often appear depressed, with a poor physical condition score [1, 49]. In severe cases, particularly in young ducklings, the disease can present as “beak atrophy and dwarfism syndrome” (BADS) or “short beak and dwarfism syndrome” (SBDS), characterized by a shortened beak, growth stunting, and enteritis [42, 45, 47]. Mortality rates can be elevated, especially when secondary infections are involved [5].

The most significant clinical impact of DuCV, however, is its role as a gateway pathogen. By crippling the immune system, DuCV dramatically increases the susceptibility of ducks to a wide range of secondary bacterial and viral infections. This is consistently observed in field and experimental settings. Co-infection with Riemerella anatipestifer, Escherichia coli, Pasteurella multocida, and Salmonella spp. is extremely common [3, 24, 41, 46]. Experimental co-infection studies have demonstrated a clear synergistic pathogenic effect. For instance, co-infection of Cherry Valley ducks with DuCV and Avian Pathogenic E. coli (APEC) resulted in significantly enhanced APEC colonization in vivo and more severe clinical disease compared to APEC infection alone [41]. Similarly, co-infection with DuCV and fowl adenovirus serotype 4 (FAdV-4) led to more pronounced pericardial effusion, hepatitis, and immunosuppression than single infections [40]. The most well-documented synergistic interaction is with novel goose parvovirus (NGPV) and goose parvovirus (GPV). Co-infection with DuCV and NGPV or GPV is a primary driver of SBDS and feather shedding syndrome (FSS), with co-infected ducks showing more severe growth retardation, immunosuppression, tissue damage, and higher viral loads of both pathogens [42-44, 47]. The immunosuppression induced by DuCV allows these other pathogens to replicate to higher titers and cause more extensive pathology, leading to the severe clinical syndromes observed in the field.

Persistent Infection and Transmission Dynamics

A defining feature of DuCV pathogenesis is its ability to establish persistent infections. Viral DNA can be detected in serum, cloacal swabs, and tissues for weeks to months after initial infection [1, 15]. In Pekin ducks, viral shedding was detectable for up to 10 weeks post-infection [15]. This persistence is facilitated by the virus’s ability to evade immune clearance, likely through its immunosuppressive effects and possibly through the establishment of a low-level, chronic replication cycle. Horizontal transmission is the primary route of spread, occurring via the fecal-oral and cloacal-fecal routes [23]. The detection of virus in throat swabs also suggests the potential for respiratory transmission [1]. The high viral load in feces and the stability of the non-enveloped virion in the environment contribute to efficient farm-to-farm and within-flock transmission.

Vertical transmission is another critical, albeit less understood, route. Shen et al. (2024) provided definitive experimental evidence that oral infection of female breeding ducks leads to infection of the oviduct, ovary, and follicles, and subsequently to the infection of fertilized eggs and hatched ducklings [26]. This finding confirms that DuCV can be transmitted from parent to offspring, which has profound implications for disease control in breeding flocks. The virus’s ability to infect the reproductive tract and be passed through the egg represents a major challenge for eradication efforts. The epidemiological significance of this is underscored by the high prevalence of DuCV in ducklings as young as one day old [1, 3]. The complex interplay between horizontal and vertical transmission ensures the virus’s continued circulation and persistence within duck populations worldwide, making it a formidable pathogen for the global duck industry.

Immune Response and Immunosuppression Induced by Duck Circovirus

The hallmark of duck circovirus (DuCV) infection is the induction of a profound and multifaceted immunosuppression, which is the primary driver of its economic impact and pathogenesis in duck populations worldwide. This immunosuppressive state is not merely a laboratory observation but is the central pathophysiological mechanism that predisposes infected birds to a cascade of secondary infections, exacerbates clinical disease, and perpetuates viral persistence within flocks [1, 5, 41]. The virus orchestrates this immune subversion through a coordinated assault on primary and secondary lymphoid organs, intricate molecular manipulation of host signaling pathways, and the dysregulation of both humoral and cellular immune effectors.

Pathological Destruction of Lymphoid Architecture

The most conspicuous evidence of DuCV-induced immunosuppression is the direct and severe damage inflicted upon the central and peripheral immune organs. Experimental infections consistently demonstrate significant atrophy of the bursa of Fabricius (BF), thymus, and spleen, which is reflected in significantly decreased immune organ indexes [1, 15]. In Cherry Valley meat ducks infected with DuCV-1, the thymus was identified as the organ harboring the highest viral titer, underscoring its role as a primary site of viral replication and immunopathogenesis [1]. Histopathological examination of these organs reveals a consistent pattern of destruction: lymphocytic depletion, hemorrhagic necrosis, and the degeneration of follicular architecture. In the bursa of Fabricius, the site of B-cell maturation, this manifests as a marked reduction in the number and size of lymphoid follicles, with the medullary region showing extensive cellular loss and lymphocyte apoptosis [15, 34]. Similarly, the spleen, a critical hub for antigen presentation and systemic immune surveillance, exhibits extensive lymphocyte depletion within the periarteriolar lymphatic sheaths and germinal centers [2, 48].

This lymphoid depletion is driven, at least in part, by the induction of apoptosis. The DuCV2 ORF3 protein (open reading frame 3) has been identified as a key viral determinant of this process. Studies in duck embryo fibroblasts (DEFs) have demonstrated that the ORF3 protein directly activates the mitochondrial (intrinsic) apoptotic pathway, characterized by the upregulation of caspase 3 and caspase 9, the cleavage of poly ADP-ribose polymerase (PARP), and the release of cytochrome c, leading to nuclear shrinkage and chromosomal DNA breakage [8]. The C-terminal 20 amino acid residues of the ORF3 protein are critical for this pro-apoptotic function, as their deletion significantly reduces apoptosis rates and downregulates key mitochondrial pathway molecules [8]. The loss of lymphocytes through this programmed cell death mechanism directly reduces the pool of immunocompetent cells available to respond to DuCV and other pathogens.

Molecular Mechanisms of Immune Subversion

Beyond the wholesale destruction of lymphoid tissue, DuCV employs sophisticated molecular strategies to dismantle antiviral signaling and facilitate a permissive environment for its own replication. A critical mechanism involves the exploitation of the host cell's tight junction machinery. The viral capsid (Cap) protein directly binds to the extracellular loop domains (EL1 and EL2) of the cellular tight junction protein CLDN2. This interaction, discovered in the oviducts of infected female breeding ducks, triggers the activation of the MAPK-ERK signaling pathway [26]. Activation of this pathway leads to the upregulation of the transcription factor SP5, which in turn drives enhanced transcription of the CLDN2 gene. The increased surface expression of CLDN2 then provides more docking sites for the virus, facilitating greater viral adhesion to target organs and promoting both horizontal and vertical transmission [26]. This mechanism demonstrates how DuCV actively remodels the host cell surface to enhance its own infectivity, creating a feed-forward loop of infection that bypasses normal cellular barriers.

The virus also directly manipulates the cytokine network, skewing the immune response away from an effective antiviral state. DuCV infection induces a significant imbalance in the production of key cytokines. Specifically, infected ducks exhibit a marked increase in the immunosuppressive cytokine interleukin-10 (IL-10), alongside a concurrent decrease in pro-inflammatory and antiviral cytokines, including interferon-gamma (IFN-γ), interleukin-12 (IL-12), and soluble CD4 (sCD4) and CD8 (sCD8) molecules [41]. The elevation of IL-10 is a canonical strategy employed by many persistent viruses to dampen T-cell responses and antigen presentation, thereby blunting the host's ability to clear the infection. The reduction in IFN-γ, a master regulator of cell-mediated immunity, further compromises the capacity of natural killer (NK) cells and cytotoxic T lymphocytes to eliminate virally infected cells. This microenvironment of cytokine dysregulation is established early in infection, with significant changes detectable as early as 8 days post-infection (dpi) and persisting for weeks [41].

Consequences for Humoral and Cellular Immunity

The cumulative effect of lymphoid organ atrophy and cytokine dysregulation is a severe, measurable impairment of both humoral and cellular immune functions. The lymphocyte transformation rate (LTR), a direct measure of T-cell proliferative capacity in response to mitogens, is significantly reduced in DuCV-infected ducks, confirming a state of T-cell anergy or exhaustion [41]. This functional deficit is directly correlated with the increased susceptibility to secondary infections. Crucially, DuCV infection impairs the duck's ability to mount a protective antibody response. While infected ducks do eventually produce antibodies against the virus (detectable by serological assays such as the recombinant Cap-based iELISA or VLP-based iELISA [20, 30]), the overall humoral response is delayed and suboptimal compared to a healthy, immunocompetent bird [34, 50]. This is a direct consequence of the damage to the bursa of Fabricius, the sole site of B-cell maturation in birds.

The humoral response itself is targeted by the virus. The development of serological tools has been critical in understanding this dynamic. For instance, an indirect ELISA based on the non-structural Rep protein can distinguish between antibodies generated by natural infection (which produce anti-Rep antibodies) and those induced by inactivated vaccines (which are primarily anti-Cap) [21]. This differential serology reveals that natural infection leads to a broader but ultimately less protective antibody profile. The clinical significance is profound: a compromised immune system cannot effectively control DuCV replication, leading to persistent, high-level viremia that can be detected in serum and oral/cloacal swabs from as early as 1 dpi and sustained for the duration of the experimental period (up to 10 weeks in some studies) [1, 15, 49].

The Immunological Gateway to Secondary Infection

The ultimate and most devastating consequence of DuCV-induced immunosuppression is the dramatic increase in susceptibility to a wide range of secondary bacterial and viral pathogens. This phenomenon is consistently reported across epidemiological and experimental studies. Co-infection with agents such as Riemerella anatipestifer, Escherichia coli, fowl adenovirus serotype 4 (FAdV-4), novel goose parvovirus (NGPV), and duck Tembusu virus (DTMUV) is a clinical norm rather than an exception [3, 24, 40, 42, 44, 46, 47].

The molecular basis for this synergy is the immunosuppressed state created by DuCV. Experimental co-infection models provide direct evidence of a synergistic pathogenic effect. For example, co-infection with DuCV and Avian Pathogenic Escherichia coli (APEC) not only results in more severe clinical signs but also significantly enhances the colonization ability of APEC in vivo. DuCV-infected ducks succumb to APEC infection more readily than those infected with APEC alone, with the effect becoming more pronounced as the DuCV infection progresses (e.g., at 24 dpi vs. 14 dpi) [41]. Similarly, co-infection with DuCV and NGPV leads to a more severe manifestation of short beak and dwarfism syndrome (SBDS), with higher viral loads of both pathogens, more pronounced immunosuppression, and more extensive tissue damage compared to single infections [42, 47]. A similar synergistic effect is observed with FAdV-4, where co-infected Cherry Valley ducks exhibit exacerbated hydropericardium hepatitis syndrome and immunosuppression [40].

This synergy is not merely additive but synergistic. In the early stages of co-infection with goose parvovirus (GPV) and DuCV, viral loads of both pathogens may actually be lower than in single infections, likely due to initial immune competition. However, as the infection progresses, the DuCV-mediated immunosuppression creates a permissive environment, allowing both viruses to replicate to significantly higher titers than in mono-infected ducks [44]. This "viral synergy" amplifies pathogenicity, leading to more severe clinical outcomes in the field, such as the feather shedding syndrome observed in Cherry Valley ducks, where the co-detection rate of NGPV and DuCV reaches 70% [43]. The viral plasticity of DuCV, evidenced by recombination events across genotypes [3, 11, 17] and its documented ability to cross species barriers, such as from ducks to geese [6] and its presence in wild marine ducks like the velvet scoter [18], ensures that this immunosuppressive threat is a constant and evolving challenge to global duck production.

Diagnostics and Detection Methods for Duck Circovirus

The accurate and timely detection of duck circovirus (DuCV) is paramount for understanding its epidemiology, implementing effective biosecurity measures, and mitigating the substantial economic losses it inflicts on the global waterfowl industry. The diagnostic landscape for DuCV has evolved considerably, moving from basic histopathological observation to a sophisticated arsenal of molecular, serological, and novel isothermal amplification techniques. This section provides an exhaustive analysis of these methods, critically evaluating their principles, applications, sensitivity, specificity, and suitability for various diagnostic contexts, from high-throughput laboratory screening to on-site, point-of-care detection in the field.

Molecular Detection Methods: The Cornerstone of DuCV Diagnosis

Molecular techniques, primarily polymerase chain reaction (PCR) and its advanced variants, constitute the gold standard for DuCV detection due to their exceptional sensitivity and specificity. These methods directly detect the viral genome, enabling diagnosis even in subclinical infections or when viral loads are low.

Conventional Polymerase Chain Reaction (PCR) and Nested PCR

Conventional PCR, targeting conserved regions of the DuCV genome, most commonly the replication-associated protein (rep) gene or the capsid (cap) gene, has been the foundational tool for epidemiological surveys and initial viral identification for nearly two decades. Numerous studies have relied on conventional PCR to establish the prevalence of DuCV across diverse geographic regions and duck breeds. For instance, a large-scale epidemiological investigation in China from 2018 to 2019 utilized PCR on 848 bursa samples, revealing an overall positivity rate of 36.91% across Guangdong, Guangxi, and Yunnan provinces [12]. Similarly, PCR-based screening in South Korea from 2011 to 2012 identified a 21.8% prevalence in subclinical Pekin ducks [46], and a more recent study in Northern Vietnam (2023–2024) confirmed 35.56% of pooled tissue samples as DuCV-positive via conventional PCR [4]. While invaluable for its simplicity and accessibility, conventional PCR’s sensitivity is limited, typically detecting down to 10²–10³ copies/µL [29, 32]. To enhance sensitivity, nested PCR approaches have been employed, particularly for detecting DuCV in wild bird populations where viral loads may be exceptionally low. A study on velvet scoters in Poland successfully used a broad-range nested PCR to identify a novel DuCV sequence, underscoring the method's utility for viral discovery and surveillance in non-traditional hosts [18].

Real-Time Quantitative PCR (qPCR)

The advent of real-time quantitative PCR (qPCR) has revolutionized DuCV diagnostics by providing not only qualitative detection but also precise quantification of viral nucleic acid. This capability is critical for understanding viral dynamics, pathogenesis, and the efficacy of antiviral interventions. Two primary qPCR chemistries have been applied to DuCV:

SYBR Green I-Based qPCR: This method, which relies on a fluorescent dye that binds to double-stranded DNA, offers a cost-effective and straightforward approach. A pioneering SYBR Green I-based qPCR assay targeting the rep gene demonstrated high reproducibility, with intra- and inter-assay coefficients of variation (CVs) of ≤1.89% and ≤1.26%, respectively, and a broad linear detection range from 1.31 × 10² to 1.31 × 10⁷ copies/µL [39]. This assay was instrumental in investigating potential vertical transmission of DuCV, finding no positive results in embryonated eggs or newly hatched ducklings, suggesting that vertical transmission, if it occurs, may be a rare event [39]. A more advanced application is the development of a SYBR Green I-based duplex real-time PCR for the simultaneous detection of DuCV and novel goose parvovirus (NGPV), a common co-pathogen in beak atrophy and dwarfism syndrome (BADS). This duplex assay distinguished the two viruses based on distinct melting temperatures (Tm: 80°C for DuCV, 84.5°C for NGPV), achieving a detection limit of 10¹ copies/µL for both targets [51].

Hydrolysis Probe-Based (TaqMan) qPCR: Probe-based qPCR offers superior specificity compared to SYBR Green, as the signal is generated only upon hybridization of a sequence-specific probe. A dual-labeled hydrolysis probe-based qPCR assay was developed to simultaneously detect both DuCV genotypes (DuCV-1 and DuCV-2). This assay exhibited a high sensitivity of 20 copies/µL, excellent intra-assay (CV ≤ 0.73%) and inter-assay (CV ≤ 1.89%) reproducibility, and no cross-reactivity with other common duck pathogens [31]. The ability to genotype in a single reaction is a significant advantage for epidemiological monitoring, given the co-circulation of multiple genotypes and the emergence of novel subtypes like DuCV-1d [11, 14].

Multiplex and Digital PCR: Advancing High-Throughput and Absolute Quantification

The complexity of co-infections in duck flocks has driven the development of multiplex PCR assays capable of detecting several pathogens simultaneously. A quadruplex real-time qPCR method was recently established for the differential detection of Muscovy duck parvovirus (MDPV), Goose parvovirus (GPV), DuCV, and Duck adenovirus 3 (DAdV-3). This assay demonstrated exceptional analytical performance, with a detection limit of 1 copy/µL for DuCV, no cross-reactivity with a panel of nine other avian pathogens, and over 99.56% agreement with conventional assays when applied to 396 clinical samples [22]. This high-throughput capability is invaluable for routine surveillance and outbreak investigations.

For absolute quantification without the need for standard curves, digital PCR (dPCR) has emerged as a superior technique. A multiplex dPCR assay for the simultaneous detection of duck Tembusu virus (DTMUV), DuCV, and new duck reovirus (NDRV) was shown to be ten times more sensitive than multiplex qPCR, with a detection limit of 1.3 copies/µL. In clinical testing of 173 samples, dPCR detected approximately 4% more positive cases for each pathogen than qPCR, with excellent agreement (kappa values > 0.85) between the two methods [27]. The enhanced sensitivity of dPCR is particularly advantageous for detecting low-level viral loads in carrier animals or environmental samples, providing a more accurate picture of viral prevalence.

Isothermal Amplification Methods: Enabling Rapid, Point-of-Care Diagnostics

The reliance on thermocyclers for PCR-based methods limits their deployment in resource-limited settings or for on-farm, real-time diagnosis. Isothermal amplification techniques, which operate at a constant temperature, offer a compelling alternative for rapid, field-deployable detection.

Loop-Mediated Isothermal Amplification (LAMP)

LAMP is a highly specific and sensitive method that amplifies DNA with high efficiency under isothermal conditions (typically 60–65°C) using a set of four to six specially designed primers. A LAMP assay targeting the rep gene of DuCV was developed, with the reaction completed in 50 minutes at 62°C. The results can be visualized directly by the naked eye through a color change, eliminating the need for specialized equipment. This assay demonstrated a sensitivity of 20 copies of DuCV DNA and showed no cross-reactivity with other duck pathogens, making it a practical tool for rapid, on-site screening [37].

Recombinase Polymerase Amplification (RPA) and Recombinase-Aided Amplification (RAA)

RPA and RAA are emerging isothermal technologies that operate at a lower, more ambient temperature (37–42°C) and offer even faster amplification times (15–30 minutes) than LAMP. A real-time fluorescence-based RAA (RF-RAA) assay for DuCV was established, with detectable results at 41°C after just 15 minutes. This method was 10 times more sensitive than qPCR and 10,000 times more sensitive than conventional PCR, with a detection limit of 1 copy/µL [29]. The specificity was confirmed against a panel of other duck and porcine viruses.

To further simplify detection and eliminate the need for real-time fluorescence readers, RPA has been coupled with lateral flow strips (LFS) and CRISPR/Cas12a technology. A pioneering RPA-CRISPR/Cas12a-LFS method targeting the DuCV rep gene was developed for visual, on-site detection. The entire process, from sample to result, takes only 45 minutes at 37°C, and the result is read on a simple dipstick, similar to a pregnancy test. This method achieved a remarkable detection limit of 2.6 gene copies and demonstrated 100% concordance with qPCR when testing 97 waterfowl samples [25]. Similarly, an RAA-LFD (lateral flow dipstick) assay was developed, providing a detection limit of 10² copies/µL within 20 minutes at 37°C, with results visualized on a dipstick in 2–3 minutes [32]. These integrated platforms represent the pinnacle of point-of-care diagnostics, combining the sensitivity of nucleic acid amplification with the simplicity of visual readout, making them ideal for surveillance in remote farms or during outbreak responses.

Serological Detection Methods: Unveiling the History of Infection

While molecular methods detect active viral infection, serological assays detect antibodies, providing crucial information about past exposure, immune status, and the effectiveness of vaccination programs. The development of robust serological tools for DuCV has been challenging due to the difficulty in producing stable, high-quality viral antigens.

Recombinant Capsid Protein-Based Indirect ELISA

The capsid (Cap) protein, the sole structural protein of DuCV, is the primary target for serological assays. An indirect enzyme-linked immunosorbent assay (iELISA) using a recombinant Cap protein expressed in Escherichia coli was developed and validated. This assay demonstrated high diagnostic performance, with 97.5% sensitivity and 98.1% specificity, an area under the ROC curve of 0.996, and no cross-reactivity with antibodies against duck Tembusu virus, duck viral enteritis virus, or Riemerella anatipestifer [20]. The assay’s reproducibility was excellent, with intra- and inter-assay CVs below 6.5% and 9.1%, respectively [20].

A significant advancement in serodiagnosis is the ability to differentiate between infected and vaccinated animals (DIVA). A novel iELISA based on the non-structural Rep protein was developed for this purpose. When applied to serum samples from vaccinated ducks, the Rep-ELISA showed a positive detection rate of only 10%, compared to 91% for a conventional Cap-based ELISA, confirming its ability to distinguish natural infection from vaccine-induced immunity [21]. This DIVA capability is critical for monitoring the success of future vaccination campaigns and for epidemiological surveillance in vaccinated populations.

Virus-Like Particle (VLP)-Based ELISA

To overcome the limitations of using monomeric recombinant proteins, which may not fully represent native antigenic conformations, a VLP-based iELISA was developed. The full-length Cap protein of DuCV-2 was expressed in E. coli and refolded to self-assemble into VLPs (~15 nm in diameter), confirmed by transmission electron microscopy. These VLPs elicited stronger antibody responses in ducks than Cap monomers, indicating superior antigenicity. The VLP-based iELISA exhibited high sensitivity (detectable up to a 1:6400 serum dilution), strong specificity (no cross-reactivity), and excellent repeatability (CV < 5%). Application to 290 field sera from Jiangsu Province, China (2022–2024), revealed a 19.96% seropositivity rate, demonstrating its utility for large-scale epidemiological monitoring [30].

Immunohistochemistry and Monoclonal Antibody-Based Detection

For direct visualization of viral antigens within tissues, immunohistochemistry (IHC) is an indispensable tool. IHC allows for the precise localization of DuCV in specific cell types, providing insights into viral tropism and pathogenesis. A study using IHC demonstrated that DuCV has a higher tropism for epithelial cells of the bile duct than for other cell types in the liver, linking the virus to primary sclerosing cholangitis [33]. IHC has also been used to confirm the extended viral distribution in the liver, kidney, duodenum, spleen, and bursa of Fabricius during co-infection with goose parvovirus [44].

The development of specific monoclonal antibodies (mAbs) against the DuCV Cap protein has further refined antigen detection. A mAb was generated that recognizes a linear epitope (144IDKDGQIV151) exposed on the surface of the virion. This mAb was successfully used in immunofluorescence and Western blot assays to detect native viral antigen in infected cell cultures (RAW267.4 macrophages) and in tissue samples from clinically infected ducks [28]. Such mAbs are invaluable reagents for standardizing diagnostic assays, studying viral replication, and developing immunodiagnostic kits.

Sample Types and Diagnostic Considerations

The choice of sample type is critical for diagnostic sensitivity. DuCV exhibits broad tissue tropism, but viral loads vary significantly across organs and over the course of infection. Studies have consistently shown that immune organs harbor the highest viral titers. The thymus was identified as the organ with the highest viral titer in Cherry Valley meat ducks [1], while the spleen was the primary target in SPF ducks, exhibiting the highest viral load and most significant histopathological changes [2]. In Pekin ducks, the spleen and bursa of Fabricius (BF) were found to have the highest mean viral loads [15]. For live animal sampling, cloacal and throat swabs are effective, with DuCV DNA detectable as early as 1 day post-infection (DPI) and persisting throughout the experimental period [1, 15]. Serum is also a reliable sample for detecting viremia, which can be detected from 1 DPI [1] or 1-week post-infection [15]. For post-mortem diagnosis, the spleen, BF, thymus, and liver are the most sensitive tissues for viral detection [1, 2, 15, 48]. The age of the duck is another crucial factor; epidemiological data consistently show that the highest positivity rates are found in ducks aged 21–40 days [3, 12, 36, 46], likely coinciding with the waning of maternal antibodies and increased environmental exposure.

Conclusion of Diagnostic Methods

The diagnostic toolkit for DuCV has matured into a comprehensive and sophisticated array of methods. Molecular techniques, from highly sensitive qPCR and multiplex assays to field-deployable RPA-CRISPR and LAMP platforms, provide unparalleled capabilities for detecting viral nucleic acid in diverse settings. Serological assays, particularly the novel Rep-based and VLP-based ELISAs, offer critical insights into population immunity and infection history, including the ability to differentiate infected from vaccinated animals. The integration of these advanced diagnostic methods is essential for implementing effective control strategies, understanding the complex epidemiology of DuCV, and ultimately mitigating its impact on global duck production. The continued development of rapid, accurate, and user-friendly point-of-care tests will be paramount for empowering veterinarians and farmers to make timely, informed management decisions.

Prevention, Control, and Future Perspectives

Current Landscape of Disease Management

The prevention and control of duck circovirus (DuCV) infection represent one of the most formidable challenges currently confronting the global waterfowl industry. Unlike many well-characterized viral pathogens for which robust prophylactic measures and therapeutic interventions have been developed over decades, DuCV occupies a uniquely difficult position. The virus is virtually ubiquitous in commercial duck-producing regions, with epidemiological surveys from China revealing positivity rates ranging from 21.8% in subclinical Pekin ducks in South Korea to 54.8% in Fujian Province [3, 46]. This widespread prevalence is compounded by the virus's capacity for both horizontal transmission via the fecal-oral route and, critically, vertical transmission through the hen, as demonstrated by Shen et al. (2024), who confirmed that oral infection of female breeding ducks leads to oviductal, ovarian, and follicular infection, subsequently resulting in virus-carrying ducklings upon hatching [26]. The implications for control are profound: vertical transmission establishes a reservoir of infection that cannot be eliminated through conventional biosecurity measures applied at the farm level alone, necessitating interventions targeting the breeder flock.

The absence of a commercial vaccine remains the single most critical gap in DuCV control. As Lei et al. (2024) emphasized in their comprehensive review, the lack of an efficient cell culture system for propagating DuCV to the titers required for conventional vaccine production has historically been the principal bottleneck [5]. Unlike many RNA viruses that replicate robustly in continuous cell lines, DuCV, like other circoviruses, exhibits stringent dependence on actively dividing cells and has proven exceptionally difficult to adapt to in vitro culture. This fundamental limitation has forced researchers to explore alternative vaccine platforms and has necessitated a re-evaluation of what constitutes feasible control strategies for this economically devastating pathogen.

Biosecurity and Management-Based Interventions

In the absence of effective vaccination, biosecurity assumes paramount importance. The epidemiological data consistently demonstrate that DuCV infection is most prevalent in ducks aged 21–40 days, with positive rates reaching 66.5% of total positive samples in one large-scale Chinese survey [3]. This age distribution reflects the dynamics of horizontal transmission within flocks and the progressive accumulation of susceptible individuals. Management interventions must therefore target the critical window between hatching and the onset of clinical immunosuppression. All-in-all-out production systems, stringent disinfection protocols, and the segregation of age groups are essential to breaking the cycle of transmission.

The demonstration by Li et al. (2025) that DuCV-1 can be detected in serum, cloacal swabs, and throat swabs as early as one day post-infection and persists throughout the experimental period underscores the efficiency of horizontal spread [1]. This sustained shedding means that even subclinically infected birds serve as continuous sources of environmental contamination. Furthermore, the work of Wang et al. (2022) on the interaction between DuCV and Avian Pathogenic Escherichia coli (APEC) revealed that DuCV infection significantly enhances the colonization ability of APEC in vivo, with more severe secondary infection observed at 24 days post-infection than at 14 days [41]. This temporal lag between primary viral infection and the exacerbation of secondary bacterial disease provides a potential window for targeted antimicrobial or immunomodulatory intervention, but it also highlights the insidious nature of DuCV-induced immunosuppression, which may not manifest clinically until after the damage to immune function is already established.

The detection of DuCV in wild marine ducks, specifically the velvet scoter (Melanitta fusca) off the coast of Poland, introduces an additional dimension to control considerations [18]. The existence of a wild reservoir suggests that even complete eradication from domestic flocks may be unsustainable if wild birds continue to reintroduce the virus. This realization shifts the objective from eradication to management, reducing viral load, minimizing immunosuppression, and preventing the amplification of secondary infections.

Therapeutic Interventions: Antivirals and Immunomodulators

Given the challenges associated with vaccine development, significant research effort has been directed toward identifying therapeutic agents capable of mitigating DuCV infection and its sequelae. The work of Wang et al. (2022) evaluating four plant polysaccharides, Astragalus polysaccharides (APS), pine pollen polysaccharides (PPPS), Aloe vera polysaccharides (AVE), and Ficus carica polysaccharides (FCPS), represents a particularly promising avenue [53]. In Cherry Valley ducks experimentally infected with DuCV, oral administration of APS and PPPS significantly improved immune function, reduced viral load, and mitigated DuCV-induced damage to immune organs. The finding that 1–5 days post-infection was the optimal treatment window aligns with the understanding that innate immunity must be bolstered before the virus establishes persistent infection and induces profound immunosuppression. The anti-apoptotic effects of APS and PPPS on peripheral blood lymphocytes are especially relevant, given that DuCV-induced lymphocyte apoptosis, mediated by the ORF3 protein through the mitochondrial pathway, is a primary mechanism of immunosuppression [8]. These plant-derived compounds offer the advantages of low toxicity, oral bioavailability, and potential scalability for inclusion in feed or drinking water.

Perhaps the most significant therapeutic breakthrough to date comes from Shen et al. (2023), who investigated the combined use of duck recombinant interferon-alpha (IFN-α) and an anti-cap protein polyclonal antibody [52]. The rationale for this combination is biologically compelling: IFN-α activates the innate antiviral response through the JAK-STAT signaling pathway and the induction of interferon-stimulated genes, while the polyclonal antibody provides passive immunity capable of neutralizing extracellular virions. In Cherry Valley ducks experimentally infected with DuCV, the combination therapy completely blocked DuCV infection after 13 days under experimental conditions, an outcome not achieved by either agent alone [52]. This synergistic effect likely reflects the ability of IFN-α to suppress viral replication within infected cells, thereby reducing the antigenic load that must be neutralized by antibody, while the antibody simultaneously clears extracellular virus and prevents reinfection. The therapeutic implications are substantial: this combination could be deployed as a metaphylactic strategy in outbreaks, particularly in valuable breeding stock where the prevention of vertical transmission is critical.

Vaccine Development: Progress and Persistent Challenges

The development of an effective DuCV vaccine has been pursued through multiple parallel strategies, each with distinct advantages and limitations. The work of Li et al. (2020) on an inactivated vaccine represents the most conventional approach [50]. Using DuCV propagated in peripheral blood mononuclear cells (PBMCs), the authors prepared an oil-adjuvanted inactivated vaccine and demonstrated that vaccinated Muscovy ducks developed higher neutralizing antibody titers, exhibited no feather abnormalities or growth repression upon challenge, and showed significantly lower virus shedding up to 42 days post-inoculation. While this study provides proof-of-concept that inactivated DuCV vaccines can be protective, the reliance on PBMCs for virus propagation imposes severe limitations on scalability. PBMC culture is labor-intensive, expensive, and yields insufficient virus for commercial production. Nevertheless, this approach may be feasible for autogenous vaccines tailored to specific farms or regions.

DNA vaccine technology offers a more scalable alternative. Huang et al. (2018) developed three DNA vaccines encoding the capsid (Cap) protein, including a construct in which the nuclear localization signal (NLS) was deleted and replaced with the secretory signal peptide of tissue plasminogen activator (tPA) [34]. This ingenious modification addressed a fundamental limitation of Cap-based vaccines: the native Cap protein localizes to the nucleus, where it is inefficiently processed for antigen presentation. By redirecting Cap to the secretory pathway, the authors achieved extracellular release of the antigen, enhanced antibody responses, and a protective efficacy of 90% in challenge experiments. The DNA platform offers advantages of stability, ease of production, and the ability to induce both humoral and cellular immunity. However, the requirement for intramuscular injection of individual birds limits practicality for large commercial flocks.

The most technologically sophisticated vaccine platform under development involves virus-like particles (VLPs). Yang et al. (2017) demonstrated that a codon-optimized Cap gene could be expressed at high levels in Pichia pastoris yeast, with the purified Cap protein self-assembling into VLPs of 15–20 nm diameter that closely resembled native DuCV virions [35]. The VLP platform is particularly attractive because VLPs preserve the conformational epitopes of the native virus while lacking the infectious genome, providing a superior safety profile compared to inactivated whole-virus vaccines. The yeast expression system is highly scalable, cost-effective, and already widely used in the biotechnology industry. More recently, Qiu et al. (2026) utilized VLPs assembled from full-length Cap protein expressed in E. coli to develop a VLP-based indirect ELISA, confirming the strong antigenicity and immunogenicity of these structures [30]. The transition from diagnostic applications to vaccine use is a logical next step, and the demonstration that VLP-based vaccines for other circoviruses, such as porcine circovirus type 2, are commercially successful provides a strong precedent.

Despite these promising developments, significant hurdles remain. The genetic diversity of DuCV, with at least three genotypes (DuCV-1, DuCV-2, and the recently identified DuCV-3) and numerous subtypes, raises concerns about cross-protection [9, 11]. Li et al. (2025) explicitly noted that the protective efficacy of vaccines against different DuCV genotypes needs to be carefully evaluated [3]. The emergence of recombinant strains, as documented by Dong et al. (2025) in Northern Vietnam and by numerous Chinese studies, further complicates vaccine design [4, 17]. A broadly protective vaccine may need to incorporate antigens from multiple genotypes or target conserved epitopes.

Future Perspectives: Molecular Targets and Next-Generation Strategies

The elucidation of the molecular mechanisms underlying DuCV replication and pathogenesis has opened new avenues for antiviral drug development. The detailed characterization of the DuCV Rep protein by Tao et al. (2025) represents a landmark achievement [19]. The demonstration that Rep possesses both ATPase and helicase activities, with 3′→5′ unwinding directionality, and that these activities are dependent on divalent metal ions and the presence of a 3′-terminal single-strand extension, provides a molecular blueprint for rational drug design. The Rep protein is highly conserved across DuCV genotypes, making it an ideal target for broad-spectrum antiviral agents. Small molecule inhibitors targeting the ATP-binding pocket or the metal ion coordination site of Rep could be identified through high-throughput screening or structure-based design. The development of such inhibitors would represent a paradigm shift in DuCV control, offering a therapeutic option that is independent of the host immune status and effective even in immunosuppressed birds.

The identification of CLDN2 as a host factor critical for DuCV adhesion and infection by Shen et al. (2024) provides an alternative therapeutic target [26]. The finding that DuCV Cap protein binds to the extracellular loop domains EL1 and EL2 of CLDN2, and that this interaction triggers the MAPK-ERK signaling pathway leading to CLDN2 upregulation, suggests that agents blocking this receptor-ligand interaction could prevent viral entry and dissemination. The potential for vertical transmission through the oviduct further underscores the importance of this target: CLDN2 is a tight junction protein expressed in the oviductal epithelium, and its upregulation by DuCV infection creates a positive feedback loop that enhances viral adhesion and transmission. Small molecules, peptides, or monoclonal antibodies that compete with Cap for CLDN2 binding could serve as prophylactic agents administered to breeding ducks to block vertical transmission.

The application of CRISPR-Cas technology to DuCV detection, as demonstrated by Liang et al. (2024), may also be adapted for therapeutic purposes [25]. The CRISPR-Cas13 system, which targets single-stranded RNA, or CRISPR-Cas12 systems targeting DNA, could theoretically be engineered to cleave the DuCV genome or transcripts, providing a sequence-specific antiviral approach. While the delivery of CRISPR components to target cells in vivo remains a significant challenge for poultry, the rapid progress in this field for mammalian applications suggests that poultry-specific delivery systems, perhaps based on adeno-associated viruses or lipid nanoparticles, could eventually be developed.

The recent discovery of a novel circovirus species, designated DuCV-3, by Liao et al. (2022) in Hunan province, China, with a genome size of only 1755 nucleotides and less than 64% identity to known DuCVs, serves as a stark reminder that our understanding of the circovirus diversity in ducks is far from complete [9]. The clinical significance of DuCV-3, which was identified in laying ducks with egg production decline, remains to be determined, but its emergence suggests that additional novel circoviruses may be circulating undetected. Metagenomic surveillance, as exemplified by the work of Cibulski et al. (2020) in Brazilian Pekin ducks, which identified avian gyrovirus 9 and a new avian gyrovirus species, should be expanded globally to provide early warning of emerging threats [13].

The integration of diagnostic advances with control strategies offers the most immediate path to reducing the impact of DuCV. The development of rapid, field-deployable detection methods, including the recombinase polymerase amplification (RPA)-CRISPR/Cas12a lateral flow strip described by Liang et al. (2024) and the real-time fluorescence-based recombinase-aided amplification (RF-RAA) assay reported by Li et al. (2022), enables real-time monitoring of infection status at the farm level [25, 29]. When combined with serological tools such as the differential ELISA developed by Wu et al. (2025), which distinguishes between antibodies induced by natural infection and those from vaccination using Rep and truncated Cap antigens, these diagnostics facilitate the implementation of test-and-remove strategies and the evaluation of vaccine efficacy in the field [21]. The World Organisation for Animal Health (WOAH) and the Food and Agriculture Organization (FAO) have emphasized the importance of such integrated surveillance systems for emerging infectious diseases, and DuCV should be recognized as a priority pathogen requiring coordinated international surveillance efforts.

In conclusion, the future of DuCV control lies in a multi-pronged approach that combines enhanced biosecurity, the deployment of therapeutic immunomodulators and antivirals, the development of broadly protective vaccines using VLP or DNA platforms, and the application of molecular tools for rapid detection and surveillance. The progress made in understanding the molecular biology of DuCV over the past decade, from the characterization of Rep enzyme activities to the identification of host factors mediating infection, provides a solid foundation for these efforts. The path from laboratory discovery to field application remains arduous, but the economic imperative is clear: DuCV infection, through its immunosuppressive effects and facilitation of secondary infections, represents a major constraint on the productivity and sustainability of the global duck industry.

References

[1] Li H, Xu G, Yan H, Bei L, Zhao M, Zhang R, et al.. Study on the infection characteristics and pathogenesis of duck circovirus 1 in Cherry Valley meat ducks. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.104805

[2] Guo X, Liu L, Zhu T, Gao Y, Yin D, Ma X, et al.. Characterization of a duck circovirus propagated in duck embryos: from genome to pathogenesis in SPF ducks. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.105431

[3] Li P, Zhang F, Bao C, Liu H, Yu K, Zhu H, et al.. Epidemiological investigation and analysis of the genetic evolution of duck circovirus in China, 2022. PLoS ONE. 2025. DOI: https://doi.org/10.1371/journal.pone.0323282

[4] Dong HV, Trinh DQ, Tran G, Vu TT, Nguyen T, Rattanasrisomporn A, et al.. Characterization of an Emerging Recombinant Duck Circovirus in Northern Vietnam, 2023–2024. Viruses. 2025. DOI: https://doi.org/10.3390/v17050732

[5] Lei X, Wang A, Zhu S, Wu S. From obscurity to urgency: a comprehensive analysis of the rising threat of duck circovirus. Veterinary Research. 2024. DOI: https://doi.org/10.1186/s13567-024-01265-2

[6] Xu S, Man Y, Xu X, Ji J, Mu X, Yao L, et al.. Genetic heterogeneity of duck circovirus first detected in geese from China. Poultry Science. 2024. DOI: https://doi.org/10.1016/j.psj.2024.104284

[7] Zhang T, Liu N, Zhang L, Jiang W, Fan X, Wang X, et al.. Research Note: Complete genome cloning and genetic evolution analysis of four Cherry Valley duck circovirus strains in China in 2022. Poultry Science. 2023. DOI: https://doi.org/10.1016/j.psj.2023.102920

[8] Huang J, Zhang Y, Cheng A, Wang M, Liu M, Zhu D, et al.. Duck Circovirus genotype 2 ORF3 protein induces apoptosis through the mitochondrial pathway. Poultry Science. 2023. DOI: https://doi.org/10.1016/j.psj.2023.102533

[9] Liao J, Xiong W, Tang H, Xiao C. Identification and characterization of a novel circovirus species in domestic laying ducks designated as duck circovirus 3 (DuCV3) from Hunan province, China.. Veterinary Microbiology. 2022. DOI: https://doi.org/10.1016/j.vetmic.2022.109598

[10] Jiao R, Xu X, Ji J, Li D, Yao L, Liu F, et al.. Base composition and adaptation of duck and goose circovirus for original and cross-host strains via codon-based investigation. Poultry Science. 2025. DOI: https://doi.org/10.1016/j.psj.2025.105304

[11] Ji J, Chen Q, Sui C, Yu Z, Xu X, Yao L, et al.. Novel Genotype Definition and Genome Characteristics of Duck Circovirus in Central and Eastern China.. Transboundary and Emerging Diseases. 2020. DOI: https://doi.org/10.1111/tbed.13676

[12] Liu H, Li L, Sun W, Shi N, Sun X, Jin N, et al.. Molecular survey of duck circovirus infection in poultry in southern and southwestern China during 2018 and 2019. BMC Veterinary Research. 2020. DOI: https://doi.org/10.1186/s12917-020-02301-x

[13] Cibulski S, Weber MN, Lima FEdS, Lima D, Santos HFd, Teixeira TF, et al.. Viral metagenomics in Brazilian Pekin ducks identifies two gyrovirus, including a new species, and the potentially pathogenic duck circovirus.. Virology. 2020. DOI: https://doi.org/10.1016/j.virol.2020.05.013

[14] Wang Y, Zhang D, Bai C, Guo X, Gao W, Li M, et al.. Molecular characteristics of a novel duck circovirus subtype 1d emerging in Anhui, China.. Virus Research. 2020. DOI: https://doi.org/10.1016/j.virusres.2020.198216

[15] Hong Y, Kang M, Jang H. Pathogenesis of duck circovirus genotype 1 in experimentally infected Pekin ducks. Poultry Science. 2018. DOI: https://doi.org/10.3382/ps/pey177

[16] Wu Z, Xia X, Li H, Jiang S, Ma Z, Wang X. Tandem repeat sequence of duck circovirus serves as downstream sequence element to regulate viral gene expression.. Veterinary Microbiology. 2019. DOI: https://doi.org/10.1016/j.vetmic.2019.108496

[17] Sun W, Zheng M, Cao H, Lu H, Wei X, Pan Y, et al.. Genome Sequences of a Novel Recombinant Duck Circovirus in China. Genome Announcements. 2016. DOI: https://doi.org/10.1128/genomeA.01181-16

[18] Matczuk A, Krawiec M, Wieliczko A. A new duck circovirus sequence, detected in velvet scoter (Melanitta fusca) supports great diversity among this species of virus. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0352-y

[19] Tao L, Wu C, Li N, Lin C, Tan J, Huang J. The replication protein of duck circovirus unwinds dsDNA in an ATP-driven and metal ion-dependent manner from 3′ to 5′. Frontiers in Veterinary Science. 2025. DOI: https://doi.org/10.3389/fvets.2025.1679348

[20] Luengyosluechakul T, Kulprasertsri S, Jala S, Phatthanakunanan S, Lertwatcharasarakul P. Development and validation of a recombinant capsid protein-based indirect enzyme-linked immunosorbent assay for serological detection of duck circovirus in commercial flocks. Veterinary World. 2025. DOI: https://doi.org/10.14202/vetworld.2025.3378-3389

[21] Wu M, Zhu Y, Mao M, Li B, Liang S, Li H, et al.. Development of an indirect ELISA for Duck circovirus detection based on prokaryotically expressed antigen. BMC Veterinary Research. 2025. DOI: https://doi.org/10.1186/s12917-025-05002-5

[22] Wang H, Chen J, An T, Chen H, Wang Y, Zhu L, et al.. Development and application of quadruplex real time quantitative PCR method for differentiation of Muscovy duck parvovirus, Goose parvovirus, Duck circovirus, and Duck adenovirus 3. Frontiers in Cellular and Infection Microbiology. 2024. DOI: https://doi.org/10.3389/fcimb.2024.1448480

[23] Yu C, Kim S, Liu C, Gao Y, Li Y, Park J, et al.. Epidemiological Investigation and Genetic Analysis of Duck Circovirus in Korea from 2013 to 2022. Animals. 2024. DOI: https://doi.org/10.3390/ani14243630

[24] Kulprasertsri S, Songserm T, Phatthanakunanan S, Saengnual P, Sinwat N, Khamtae R, et al.. Molecular genotyping and subgenotyping of duck circovirus at duck farms in Thailand. Veterinary World. 2024. DOI: https://doi.org/10.14202/vetworld.2024.1990-1999

[25] Liang Q, Chen W, Liu R, Fu Q, Fu G, Cheng L, et al.. CRISPR/Cas12a and recombinase polymerase amplification-based rapid on-site nucleic acid detection of duck circovirus. Virology Journal. 2024. DOI: https://doi.org/10.1186/s12985-024-02577-7

[26] Shen M, Sun Z, Wang C, Zhang S, Jia B, Huang B, et al.. Duck circovirus regulates the expression of duck CLDN2 protein by activating the MAPK-ERK pathway to affect its adhesion and infection. Journal of Virology. 2024. DOI: https://doi.org/10.1128/jvi.00497-24

[27] Yin Y, Xiong C, Shi K, Long F, Feng S, Qu S, et al.. Multiplex digital PCR: a superior technique to qPCR for the simultaneous detection of duck Tembusu virus, duck circovirus, and new duck reovirus. Frontiers in Veterinary Science. 2023. DOI: https://doi.org/10.3389/fvets.2023.1222789

[28] Li J, Liu F, Ren Z, Fu G, Shi J, Zhao N, et al.. Generation of a monoclonal antibody against duck circovirus capsid protein and its potential application for native viral antigen detection. Frontiers in Microbiology. 2023. DOI: https://doi.org/10.3389/fmicb.2023.1206038

[29] Li X, Wang C, Zhang Z, Wang C, Wang W, Zhao Z, et al.. Fast detection of duck circovirus by real-time fluorescence-based recombinase-aided amplification. Poultry Science. 2022. DOI: https://doi.org/10.1016/j.psj.2022.101707

[30] Qiu S, Guo F, Zhao L, Zhong Z, Wang Y. VLP-based indirect ELISA enables reliable sero-diagnosis and epidemiological monitoring of duck circovirus. Frontiers in Veterinary Science. 2026. DOI: https://doi.org/10.3389/fvets.2026.1735016

[31] Zhang L, Jiang W, Zhang F, Li Y, Li J, Liang S, et al.. Development of a dual-labeled, hydrolysis probe-based, real-time quantitative PCR assay for detection of both genotypes of duck circovirus-1 (DuCV-1) and DuCV-2. Virus genes. 2021. DOI: https://doi.org/10.1007/s11262-021-01862-9

[32] Li X, Wang C, Wang W, Zhang Z, Zhang Z, Wang C, et al.. Research Note: Development of rapid isothermal amplification assay for detection of duck circovirus. Poultry Science. 2021. DOI: https://doi.org/10.1016/j.psj.2021.101339

[33] Zhu D, Zhou D, Liu J, Hao X, Cheng Z. Duck circovirus induces a new pathogenetic characteristic, primary sclerosing cholangitis.. Comparative Immunology, Microbiology & Infectious Diseases. 2019. DOI: https://doi.org/10.1016/J.CIMID.2018.12.009

[34] Huang J, Yang C, Jia R, Wang M, Chen S, Liu M, et al.. Induction of a protective response in ducks vaccinated with a DNA vaccine encoding engineered duck circovirus Capsid protein.. Veterinary Microbiology. 2018. DOI: https://doi.org/10.1016/j.vetmic.2018.09.002

[35] Yang C, Yu X, Jia R, Liu S, Wang M, Zhu D, et al.. The codon-optimized capsid gene of duck circovirus can be highly expressed in yeast and self-assemble into virus-like particles. Journal of Integrative Agriculture. 2017. DOI: https://doi.org/10.1016/S2095-3119(16)61605-2

[36] Jeong H, Baek K, Koh W, Lee J. Prevalence of infection and genetic analysis of duck circovirus in Jeonbuk province. . 2016. DOI: https://doi.org/10.7853/KJVS.2016.39.1.59

[37] Xie L, Xie Z, Zhao G, Liu J, Pang Y, Deng X, et al.. A loop-mediated isothermal amplification assay for the visual detection of duck circovirus. Virology Journal. 2014. DOI: https://doi.org/10.1186/1743-422X-11-76

[38] Cha S, Kang M, Cho JG, Jang H. Genetic analysis of duck circovirus in Pekin ducks from South Korea.. Poultry Science. 2013. DOI: https://doi.org/10.3382/ps.2013-03331

[39] Wan C, Huang Y, Cheng L, Fu G, Shi S, Chen H, et al.. The development of a rapid SYBR Green I-based quantitative PCR for detection of Duck circovirus. Virology Journal. 2011. DOI: https://doi.org/10.1186/1743-422X-8-465

[40] Shen M, Gao P, Wang C, Li N, Zhang S, Jiang Y, et al.. Pathogenicity of duck circovirus and fowl adenovirus serotype 4 co-infection in Cherry Valley ducks.. Veterinary Microbiology. 2023. DOI: https://doi.org/10.1016/j.vetmic.2023.109662

[41] Wang X, Li L, Shang H, Zhou F, Wang C, Zhang S, et al.. Effects of duck circovirus on immune function and secondary infection of Avian Pathogenic Escherichia coli. Poultry Science. 2022. DOI: https://doi.org/10.1016/j.psj.2022.101799

[42] Li H, Bei L, Yan H, Zhao M, Zhang R, Meng Y, et al.. Pathogenesis of NGPV and DuCV CO-infection pathogenicity analysis of co-infection with novel goose parvovirus and duck circovirus in Cherry Valley meat ducks.. Poultry Science. 2026. DOI: https://doi.org/10.1016/j.psj.2026.106653

[43] Yang Y, Sui N, Zhang R, Lan J, Li P, Lian C, et al.. Coinfection of novel goose parvovirus–associated virus and duck circovirus in feather sacs of Cherry Valley ducks with feather shedding syndrome. Poultry Science. 2020. DOI: https://doi.org/10.1016/j.psj.2020.05.013

[44] Liu J, Yang X, Hao X, Feng Y, Zhang Y, Cheng Z. Effect of Goose Parvovirus and Duck Circovirus Coinfection in Ducks. Journal of Veterinary Research. 2020. DOI: https://doi.org/10.2478/jvetres-2020-0048

[45] Li P, Li J, Zhang R, Chen J, Wang W, Lan J, et al.. Duck "beak atrophy and dwarfism syndrome" disease complex: Interplay of novel goose parvovirus-related virus and duck circovirus?. Transboundary and Emerging Diseases. 2018. DOI: https://doi.org/10.1111/tbed.12812

[46] Cha S, Song E, Kang M, Wei B, Seo H, Roh J, et al.. Prevalence of Duck Circovirus Infection of Subclinical Pekin Ducks in South Korea. Journal of Veterinary Medical Science. 2013. DOI: https://doi.org/10.1292/jvms.13-0447

[47] Zhu Y, Wu Q, Wu M, He D, Wu B, Mao M, et al.. Pathogenicity of duck circovirus and novel goose parvovirus co-infection in SPF ducks. Avian Pathology. 2024. DOI: https://doi.org/10.1080/03079457.2024.2383231

[48] Cui X, Zhu Y, Wu Q, He D, Mao M, Wei F, et al.. Pathogenicity of duck circovirus 1 in experimentally infected specific pathogen-free ducks. Poultry Science. 2023. DOI: https://doi.org/10.1016/j.psj.2023.103301

[49] Li P, Zhang Z, Jia R, Mao S, Wang M, Jia R, et al.. Rescue of a duck circovirus from an infectious DNA clone in ducklings. Virology Journal. 2015. DOI: https://doi.org/10.1186/s12985-015-0312-6

[50] Li Z, Fu G, Feng Z, Chen J, Shi S, Liu R, et al.. Evaluation of a novel inactivated vaccine against duck circovirus in muscovy ducks.. Veterinary Microbiology. 2020. DOI: https://doi.org/10.1016/j.vetmic.2019.108574

[51] Wang Y, Cui Y, Li Y, Jiang S, Liu H, Wang J, et al.. Simultaneous detection of duck circovirus and novel goose parvovirus via SYBR green I-based duplex real-time polymerase chain reaction analysis. Molecular and Cellular Probes. 2020. DOI: https://doi.org/10.1016/j.mcp.2020.101648

[52] Shen M, Zhang S, Mao Y, Wang C, Gao P, Li N, et al.. Effect of duck interferon-α and an anti-cap protein polyclonal antibody against duck circovirus.. Microbial Pathogenesis. 2023. DOI: https://doi.org/10.1016/j.micpath.2023.106235

[53] Wang X, Zhang S, Shang H, Wang C, Zhou F, Liu Y, et al.. Evaluation of the antiviral effect of four plant polysaccharides against duck circovirus.. Research in Veterinary Science. 2022. DOI: https://doi.org/10.1016/j.rvsc.2022.09.009